| Jeff A. Wolf |
Founder of 9 different companies, including: Heat Biologics, Inc., Avigen, Inc. and Seed-One Ventures LLC, Jeff A. Wolf is an entrepreneur and businessperson who has been at the helm of 5 different companies and currently is Chairman, President & Chief Executive Officer of Heat Biologics, Inc. (which he founded in 2008). He is also on the board of Elusys Therapeutics, Inc. (former Chairman), Pelican Therapeutics, Inc. and Synthetic Biologics, Inc.
In his past career he held the position of Chairman & Chief Executive Officer for GenerationOne, Inc. (he founded the company in 2011), Managing Director at Sunrock Equity Partners LLC, Managing Director at Seed-One Ventures LLC (he founded the company in 1997), Chairman & Chief Executive Officer at Elusys Therapeutics, Inc. (he founded the company), Chairman for TYRX, Inc. (he founded the company in 1998), Managing Director at Castle Group Ltd. and Director at Avigen, Inc.
He received an undergraduate degree from The University of Chicago, a graduate degree from New York University School of Law and an MBA from Stanford Graduate School of Business. |
| George E. Peoples |
George E. Peoples founded Cancer Insight LLC. Presently, Dr. Peoples is Chief Medical Advisor at Heat Biologics, Inc. and Chief Medical Officer for Pelican Therapeutics, Inc. (a subsidiary of Heat Biologics, Inc.). Dr. Peoples is also on the board of Cancer Insight LLC and Chief Medical Officer & Director at Orbis Health Solutions LLC and Professor at Uniformed Services University of the Health Sciences.
He previously was Chief-Surgical Oncology at Brooke Army Medical Center, Deputy Director at United States Military Cancer Institute and Chief-Surgical Oncology at Walter Reed Amy Medical Center.
George E. Peoples received an undergraduate degree from US Military Academy and an undergraduate degree from The Johns Hopkins University School of Medicine. |
| William L Ostrander |
Currently, William L Ostrander occupies the position of Chief Financial Officer, Secretary & Controller at Heat Biologics, Inc.
He previously was Senior Director-Finance & Accounting at KBI Biopharma, Inc., Executive Director at Liquidia Technologies, Inc., Senior Manager-Finance at Boca Research, Inc., Finance Manager at Lexisnexis Risk Solutions Inc. and Controller of LexisNexis Risk Data Management, Inc.
He received an undergraduate degree from Central Michigan University. |
| Edward Byron Smith |
Edward Byron Smith founded Brightline Capital Management LLC. Presently, Mr. Smith is Managing Member at Aristar Capital Management LLC. Mr. Smith is also on the board of Heat Biologics, Inc., Population Bio, Inc. and Pelican Therapeutics, Inc. and Managing Member at Brightline Ventures I B LLC, Managing Member at Brightline Ventures I C LLC and Managing Member at Brightline Ventures I LLC.
In his past career he occupied the position of Director at Agritech Worldwide, Inc., Managing Member at Brightline Capital Management LLC, Analyst at P&S Capital Partners LLC, Associate for GTCR LLC and Analyst at Credit Suisse First Boston LLC.
Mr. Smith received an undergraduate degree from Harvard College and an MBA from Harvard Business School. |
| John James Monahan |
John James Monahan founded Avigen, Inc. and Tacere Therapeutics, Inc. He is on the board of Heat Biologics, Inc. and 4 other companies.
Dr. Monahan previously occupied the position of Director-Molecular & Cell Biology at Triton Biosciences, Inc., Chief Executive Officer of Avigen, Inc., Vice President-Research & Development for Somatix Therapy Corp., Chief-Research Group & Molecular Genetics at Hoffmann-La Roche, Inc., Instructor at Baylor College of Medicine and Director at Tacere Therapeutics, Inc.
John James Monahan received a doctorate from McMaster University and an undergraduate degree from University College Dublin. |
